LumiThera Inc., a medical technology company offering photobiomodulation (PBM) to treat eye injuries and diseases, today announced it has completed the acquisition of Diopsys, Inc., a leading provider of advanced medical Visual electrophysiology devices that help ophthalmologists analyze the entire visual pathway for visual and neuro-visual disorders. Diopsys is now a wholly owned subsidiary of LumiThera.